Co-Founder

Dr. Stegmann, M.D., and Professor of Surgery, is the cardiac surgeon who pioneered the procedure upon which CVBT was founded. For the past 13 years, he has been working in the area of neo-angiogenesis and human growth factors, prompting a discovery that opens a new area of biotechnology, and introduces a new type of “physiological” treatment for all kinds of atherosclerotic cardiovascular diseases. Besides various scientific publications, he has since authored New Vessels for the Heart, the story of his discovery and its development.

From December 1984 until March 2006, Dr. Stegmann held the position of the Director of the Department for Thoracic and Cardiovascular Surgery at the Fulda Medical Center in Germany, a major medical and teaching hospital serving the University of Marburg and the greater Frankfurt, Germany, area. He is also a member of the Faculty of Hannover Medical School in Germany. He received his medical degree (summa cum laude) from Heidelberg University, Heidelberg, Germany.

Dr. Stegmann has published more than 200 scientific papers in international journals; he also is a member of various international societies and associations in the cardiovascular area.

Additionally, Dr. Stegmann has been awarded the “Rudolf – Nissen – Memorial – Prize” by the German Society for Thoracic and Cardiovascular Surgery (1982), and is a member of the Faculty of Hannover Medical School, Germany and Faculty Member of “Trans-Catheter Therapeutics” (TCT), Cardiovascular Research Foundation (CRF), New York, USA. Thomas also has the privileged distinction to be an Honorary Member of the “Rideau Institute of Canada”.

< Back to Scientists

< Back to Officers & Key Personnel

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.